5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.15▼ | 5.14▲ | 5.14▲ | 5.15▼ | 5.30▼ |
MA10 | 5.12▲ | 5.13▲ | 5.13▲ | 5.17▼ | 5.07▲ |
MA20 | 5.15▼ | 5.16▼ | 5.16▼ | 5.34▼ | 4.22▲ |
MA50 | 5.42▼ | 5.55▼ | 5.46▼ | 5.18▼ | 4.24▲ |
MA100 | 5.76▼ | 5.24▼ | 5.09▲ | 4.10▲ | 6.20▼ |
MA200 | 5.18▼ | 5.17▼ | 4.79▲ | 4.05▲ | 22.71▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.026▲ | 0.021▲ | 0.018▲ | -0.056▼ | 0.163▲ |
RSI | 43.917▼ | 44.571▼ | 45.066▼ | 49.264▼ | 56.720▲ |
STOCH | 68.091 | 47.202 | 44.931 | 48.641 | 41.575 |
WILL %R | -37.838 | -52.083 | -52.083 | -64.064 | -63.814 |
CCI | 38.230 | 6.119 | 14.059 | -48.014 | 35.797 |
Tuesday, August 26, 2025 12:00 AM
Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty ...
|
Thursday, August 21, 2025 10:42 AM
(RTTNews) - Evoke Pharma (EVOK) announced that U.S. Patent No. 12,377,064 for GIMOTI - metoclopramide, nasal spray, used to treat moderate to severe gastroparesis, has been added to the FDA's Orange ...
|
Thursday, August 21, 2025 08:20 AM
Shares of Evoke Pharma, Inc. (NASDAQ:EVOK) jumped 19% on Thursday after the company announced that a new patent for its GIMOTI nasal spray has been included in the FDA’s Orange Book. The specialty ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 5.155 | 5.155 | 5.145 | 5.145 | 9,245 |
16/09/25 | 5.01 | 5.22 | 5.01 | 5.18 | 14,348 |
15/09/25 | 5.23 | 5.27 | 5.00 | 5.07 | 25,476 |
12/09/25 | 5.1447 | 5.23 | 5.10 | 5.17 | 19,671 |
11/09/25 | 5.14 | 5.23 | 5.06 | 5.18 | 34,249 |
10/09/25 | 5.20 | 5.24 | 5.06 | 5.06 | 18,523 |
09/09/25 | 5.00 | 5.25 | 4.9066 | 5.175 | 23,662 |
08/09/25 | 5.091 | 5.26 | 5.01 | 5.20 | 69,869 |
05/09/25 | 5.20 | 5.2639 | 5.1603 | 5.21 | 9,716 |
04/09/25 | 5.16 | 5.31 | 5.16 | 5.29 | 8,413 |
|
|
||||
|
|
||||
|
|